AVXL Earnings

Quarterly EPS
$-0.14
Q4 2024
$-0.14
Q1 2025
$-0.13
Q2 2025
$-0.16
Q3 2025
$-0.11
Q4 2025
$-0.06
Q1 2026
$-0.06
Q2 2026
$0.08
Q3 2026
Latest RevenueN/A
Latest Net Income7.8M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026$0.0807.8M—+150.0%
Q2 2026-$0.060-5338000—+53.8%
Q1 2026-$0.060-5681000—+57.1%
Q4 2025-$0.110-9827000—+21.4%
Q3 2025-$0.160-13243000—-14.3%
Q2 2025-$0.130-11196000—+0.0%
Q1 2025-$0.140-12111000—-27.3%
Q4 2024-$0.140-11620000—-16.7%
Q3 2024-$0.140-12214000——
Q2 2024-$0.130-10546000——
Q1 2024-$0.110-8622000——
Q4 2023-$0.120-10146000——
Anavex Life Sciences (AVXL) — Earnings